Polydonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: Regulation by interleukin (Il)-2, Il-15, and Bcl-2

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1735-1747

  Zaunders, John J ^a   Moutouh De Parseval, Laure ^c   Kitada, Shinichi ^f   Reed, John C ^f   Rought, Steffney ^c,d   Genini, Davide ^d   Leoni, Lorenzo ^d   Kelleher, Anthony ^b   Cooper, David A ^b   Smith, Don E ^b   Grey, Pat ^b   Estaquier, Jérôme ^e   Little, Susan ^c,d   Richman, Douglas D ^c,d   Corbeil, Jacques ^c,d  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e BICHAT HOSPITAL   (France)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR BETA CHAIN; CASPASE; IL15RA PROTEIN, HUMAN; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR; RNA;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; CELL DIVISION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADULT; APOPTOSIS; CASPASES; CELL DIVISION; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CCR5; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; RNA; T-LYMPHOCYTE SUBSETS;

EID: 0037526584     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375030     Document Type: Article

References (89)

1. Schacker T, Little S, Connick E, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001; 183:555-62.
2. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-77.
3. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261:1179-81.
4. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185:621-8.
5. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185:1681-91.
6. + T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis 2000; 181:927-32.
7. - CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection. J Infect Dis 2001; 183:736-43.
8. + T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 2000; 74:11001-7.
9. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69:217-45.
10. Smith KA. Interleukin 2. Annu Rev Immunol 1984; 2:319-33.
11. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001; 22:564-71.
12. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999; 17:19-49.
13. Perera LP, Goldman CK, Waldmann TA. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol 1999; 162:2606-12.
14. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 1999; 189:1735-46.
15. + T cells in vivo by IL-15. Immunity 1998; 8:591-9.
16. Gaines H, von Sydow MA, von Stedingk LV, et al. Immunological changes in primary HIV-1 infection. AIDS 1990; 4:995-9.
17. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96:2951-64.
18. + patients. Am J Pathol 1995; 146:1542-55.
19. Adachi Y, Oyaizu N, Than S, McCloskey TW, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 1996; 157:4184-93.
20. + T lymphocytes during HIV infection. J Immunol 1996; 156:2282-93.
21. + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 1992; 80:452-8.
22. Akbar AN, Borthwick N, Salmon M, et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: the role of apoptosis in T cell memory. J Exp Med 1993; 178:427-38.
23. + T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest 2000; 106:1251-61.
24. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J Clin Invest 1994; 93:982-8.
25. Cossarizza A, Mussini C, Mongiardo N, et al. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 1997; 11:19-26.
26. Cossarizza A, Stent G, Mussini C, et al. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. AIDS 2000; 14:345-55.
27. von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997; 7:147-54.
28. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell PC. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987; 236:1295-9.
29. + T cells deficient in the IL-15 receptor α-chain. J Immunol 2002; 168:705-12.
30. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996; 87:4959-66.
31. Naora H, Gougeon ML. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals: correlation with its ability to increase BCL-2 expression. Cell Death Differ 1999; 6:1002-11.
32. Genini D, Sheeter D, Rought S, et al. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J 2001; 15:5-6.
33. Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS 1991; 5:1-14.
34. Zaunders JJ, Cunningham PH, Kelleher AD, et al. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis 1999; 180:320-9.
35. Little SJ, Daar ES, D'Aquila RT, et al. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA 1999; 282:1142-9.
36. Moutouh L, Estaquier J, Richman DD, Corbeil J. Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors. J Virol 1998; 72:8061-72.
37. Poot M, Pierce RH. Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry 1999; 35:311-7.
38. Bedner E, Smolewski P, Amstad P, Darzynkiewicz Z. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res 2000; 259:308-13.
39. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171:131-7.
40. Giri JG, Kumaki S, Ahdieh M, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995; 14:3654-63.
41. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984; 133:1710-5.
42. + T lymphocytes. J Immunol 1990; 144:574-82.
43. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-6.
44. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994; 370:463-7.
45. Castedo M, Hirsch T, Susin SA, et al. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996; 157:512-21.
46. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12.
47. Kaplan D, Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J Virol 1998; 72:6279-82.
48. Bulfone-Paus S, Ungureanu D, Pohl T, et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997; 3:1124-8.
49. Chehimi J, Marshall JD, Salvucci O, et al. IL-15 enhances immune functions during HIV infection. J Immunol 1997; 158:5978-87.
50. + T cell responsiveness to antigen. J Immunol 1998; 161:2141-50.
51. Agostini C, Siviero M, Facco M, et al. Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 2001; 163:484-9.
52. Marks-Konczalik J, Dubois S, Losi JM, et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 2000; 97:11445-50.
53. Durbin JE, Fernandez-Sesma A, Lee CK, et al. Type I IFN modulates innate and specific antiviral immunity. J Immunol 2000; 164:4220-8.
54. + T cells. Proc Natl Acad Sci USA 2001; 98:6313-8.
55. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-7.
56. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9:669-76.
57. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191:771-80.
58. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168:4827-31.
59. + T cells. Proc Natl Acad Sci USA 1999; 96:8597-602.
60. Haanen JB, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TN. Systemic T cell expansion during localized viral infection. Eur J Immunol 1999; 29:1168-74.
61. Kuroda MJ, Schmitz JE, Seth A, et al. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. Blood 2000; 96:1474-9.
62. Kacani L, Stoiber H, Dierich MP. Role of IL-15 in HIV-1-associated hypergammaglobulinaemia. Clin Exp Immunol 1997; 108:14-8.
63. + T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection. Microbes Infect 2001; 3:181-91.
64. Chae DW, Nosaka Y, Strom TB, Maslinski W. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. J Immunol 1996; 157:2813-9.
65. Agostini C, Trentin L, Sancetta R, et al. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood 1997; 90:1115-23.
66. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-61.
67. + T cells in vivo after IL-2 treatment of patients with HIV infection. Proc Natl Acad Sci USA 2002; 99:10712-7.
68. + T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group. AIDS 1999; 13:455-63.
69. + cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
70. Graziosi C, Gantt KR, Vaccarezza M, et al. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 1996; 93:4386-91.
71. Kaur A, Yang J, Hempel D, et al. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection. J Immunol 2000; 164:934-43.
72. Selin LK, Varga SM, Wong IC, Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 1998; 188:1705-15.
73. + memory T cells by viral variants. J Exp Med 1999; 190:1319-28.
74. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-80.
75. Alter G, Merchant A, Tsoukas CM, et al. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J Infect Dis 2002; 185:755-65.
76. Wilson JD, Ogg GS, Allen RL, et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 2000; 14:225-33.
77. + T cells. J Immunol 2002; 168:2225-32.
78. + T cell subsets during virus infection: protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med 2000; 191:2159-70.
79. Kunkel EJ, Boisvert J, Murphy K, et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 2002; 160:347-55.
80. von Andrian UH, Mackay CR. T-cell function and migration: two sides of the same coin. N Engl J Med 2000; 343:1020-34.
81. Olsson J, Poles M, Spetz A-L, et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and β-chemokines. J Infect Dis 2000; 182:1625-35.
82. Meng G, Sellers MT, Mosteller-Barnum M, Rogers TS, Shaw GM, Smith PD. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J Infect Dis 2000; 182:785-91.
83. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 1999; 104:49-57.
84. Park S, Murray D, John B, Crispe IN. Biology and significance of T-cell apoptosis in the liver. Immunol Cell Biol 2002; 80:74-83.
85. Schmitz JE, Kuroda MJ, Veazey RS, et al. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. J Immunol 2000; 164:6015-9.
86. + T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection. Blood 2001; 98:3169-71.
87. Harari A, Rizzardi GP, Ellefsen K, et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002; 100:1381-7.
88. Brodie SJ, Patterson BK, Lewinsohn DA, et al. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Chin Invest 2000; 105:1407-17.
89. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555-66.